Navigation Links
Varian Announces Global Clinical Council to Develop RapidArc(TM) Cancer Treatments
Date:3/19/2008

Top cancer centers contribute to continuing development of fast and precise

form of image-guided intensity modulated radiation therapy

PALO ALTO, Calif., March 19 /PRNewswire-FirstCall/ -- Varian Medical Systems (NYSE: VAR) has formed a council of leading cancer centers in North America and Europe to further the development of clinical protocols using its revolutionary RapidArc(TM) radiotherapy technology for fast and precise cancer treatments. RapidArc makes it possible to deliver advanced image-guided, intensity-modulated radiation therapy (IMRT) two to eight times faster than is possible with conventional IMRT or helical tomotherapy.

The RapidArc council members include researchers and scientists from the VU University Medical Center in Amsterdam, Netherlands; Rigshospitalet in Copenhagen, Denmark; CRLC Val d'Aurelle in Montpellier, France; University Hospital in Zurich, Switzerland; BC Cancer Agency in Vancouver, Canada; University of Maryland Marlene and Stewart Greenebaum Cancer Center in Baltimore, USA; and University of Alabama at Birmingham, Alabama, USA.

The council members have been working with early versions of the Varian RapidArc system to potentially expand clinical applications for the new treatment method. As part of this effort, they intend to develop additional clinical presentations on the new technology for submission to scientific meetings, journals and symposia. In addition, the council members will collaborate with Varian engineers and developers in Switzerland, Finland and the US on future enhancements to the technology.

"RapidArc represents a major medical advance that has the potential to change the way radiation therapy is planned and delivered and the RapidArc Council has alre
'/>"/>

SOURCE Varian Medical Systems
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Specialized Care for Ovarian Cancer Improves Outcomes
2. Recurrent low-grade carcinoma of the ovary less responsive to chemo than more common ovarian cancers
3. Advanced-stage ovarian cancer patients with BRCA live longer, may respond better to treatment
4. Gleevec May Disrupt Ovarian Function
5. U of Minnesota study finds thalidomide shows promise for treatment of recurrent ovarian cancer
6. Researchers identify and shut down protein that fuels ovarian cancer
7. Varian Medical Systems Announces Symposia on RapidArc Technology for Faster, More Precise Radiotherapy Treatments
8. Combo Treatment Best for Melanoma, Advanced Ovarian Cancer
9. Vaccine/antibody therapy effective, milder side effects in melanoma and ovarian cancer
10. Yale test detects early stage ovarian cancer with 99 percent accuracy
11. Varian, Inc. Board Authorizes New $100 Million Stock Repurchase Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...stive and Kidney Diseases (NIDDK), part of the Nat... to eight academic research centers to conduct col... disorders by looking for clues outside the bladde...the five-year project is estimated to be up to $37... effort is an excellent example of NIH,s commitmen...
(Date:9/5/2008)... -- As the general election,campaign begins in ear...,Business ( http://www.nfib.com ) is looking to th...on the healthcare concerns of small,business. Now ... over, NFIB,is asking both candidates to fully con...inesses as they further develop their healthcare p...
(Date:9/5/2008)...are enhanced by taking into account risk factors b...ding to research teams led by epidemiologists at T...r in two complementary papers appearing in the Sep...In the first study to focus on African-Americans, ...d exposure to certain risks. Based upon these find...
(Date:9/4/2008)... presence of measles virus RNA was no more likely ...n children with only GI disturbances. Furthermore...R vaccine timing. Study findings are reported onl...r 4 ( http://dx.plos.org/10.1371/journal.pone.0003...vaccines in 1963, three to four million people wer...
Breaking Medicine News(10 mins):Health News:NIH launches unique effort to advance study of urologic chronic pelvic pain disorders 2Health News:NIH launches unique effort to advance study of urologic chronic pelvic pain disorders 3Health News:Conventions Conclude, Fall Campaign Begins: NFIB Looks for More Focus on Small Business Healthcare Concerns 2Health News:Conventions Conclude, Fall Campaign Begins: NFIB Looks for More Focus on Small Business Healthcare Concerns 3Health News:Creating lung cancer risk models for specific populations refines prediction 2Health News:Creating lung cancer risk models for specific populations refines prediction 3Health News:Study firmly shows no connection between measles, mumps, rubella (MMR) vaccine and autism 2Health News:Study firmly shows no connection between measles, mumps, rubella (MMR) vaccine and autism 3
...rs at the Kimmel Cancer Center at Thomas Jefferson...al in Philadelphia, shows that pancreatic cancer p... after surgery have nearly as good a chance as any...esearchers reviewed the records of 890 patients wi...
...g patients, warns a senior doctor in this week’s B...monest causes of delayed discharge are associated ..., healthcare acquired infections, and medication e...result of lack of trained staff, lack of continuit...
...tients between the ages of 55 and 64 in the United...86 surgeries in 2004—a nearly 2,000 percent increa... Healthcare Research and Quality. The report, the...as done on obesity surgery, also found a 726 perce...
...s bit scores of people in the Pakistani city of Ra...uld be cornered and killed, media reports said Sat...n city Friday, the sick animals set upon on a tota...women and children on their way to school and work...
Other Medicine News:Health News:Study: Older Pancreatic Cancer Surgery Survivors Live Long 2Health News:Obesity Surgeries Have Jumped Dramatically Since 1998 2
(Date:9/4/2008)...iral activity and favorable safety ... 4 /- Idenix,Pharmaceutical...any engaged,in the discovery and development of dr...ectious diseases, today announced that it has comp..., a non-nucleoside reverse,transcriptase inhibitor...
(Date:9/3/2008)...Children Studied. Wrong,Conclusions Reached., NIX...rs for Disease,Control and Prevention (CDC) study ... MMR vaccine and autism. The National Autism Assoc...l the growing public concern over a,vaccine-autism...g design,and methodology., For years, parents hav...
(Date:9/3/2008)... Disease Awareness Month, CHARLOTTESVILLE, Va., S...LC, a clinical-stage drug-development company comm...edical needs, announced today that it has begun,to... its lead drug,candidate trans sodium crocetinate ...inicaltrials.gov Website, is investigating TSC as ...
(Date:9/3/2008)... 3 Plans with FDA, PRINCETON, N.J., Sept. 3 /PRNe...ay that it successfully completed two key clinical...nnovative low-dose, once-weekly,contraceptive pat...oduct,code AG-200-15. The Phase 2b safety and effi...f ovulation suppression, cycle control and safety....
Breaking Medicine Technology:Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 2Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 3Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 4CDC Misses Target With Flawed MMR/Autism Study 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 4Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 2Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 3Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 4PTC Therapeutics Announces Initiation of Phase 2b Registration Directed Clinical Trial of PTC124 in Duchenne Becker Muscular Dystrophy 1881 1PTC Therapeutics Announces Initiation of Phase 2b Registration Directed Clinical Trial of PTC124 in Duchenne Becker Muscular Dystrophy 1881 2PTC Therapeutics Announces Initiation of Phase 2b Registration Directed Clinical Trial of PTC124 in Duchenne Becker Muscular Dystrophy 1881 3PTC Therapeutics Announces Initiation of Phase 2b Registration Directed Clinical Trial of PTC124 in Duchenne Becker Muscular Dystrophy 1881 4PTC Therapeutics Announces Initiation of Phase 2b Registration Directed Clinical Trial of PTC124 in Duchenne Becker Muscular Dystrophy 1881 5Sleep Apnea Screening Cuts Surgical Complications 17520 1Sleep Apnea Screening Cuts Surgical Complications 17520 2Charity Raffle Offers Trip and Game Tickets to Soccers Euro 2008 Quarterfinal 17517 1Charity Raffle Offers Trip and Game Tickets to Soccers Euro 2008 Quarterfinal 17517 2Ceregene Announces Two Key Additions to Leadership Team 4799 1Ceregene Announces Two Key Additions to Leadership Team 4799 2Ceregene Announces Two Key Additions to Leadership Team 4799 3
...diac surgery patients require progressive solution...urn to everyday life. Since the introduction of e... been able to provide nearly 400,000 CABG patients...ulation , Shorter hospital stays , Reduced ris...
...corrected with GP lenses. Even though good spectac...p the patient adapt to the inevitable. GP lenses w...ace and provide improved visual acuity., ,Keratoco...ienced practitioner. Each case is unique and requi...
...ted Immunoassay Analyzer that fits in any lab envi... X 21 inches and weighs approximately 60 lbs. Its...ratories, work stations for small hospitals, STAT ...cated system for specialty testing. With a throug...
... winning the hearts of cardiologists and cardiac p...operative words for Heartline™. Patients con...nd their attending physician know that a professio...n is only a phone call away. ,Heartline™ ...
Medicine Products: